In this patient case, a 72-year-old male with primary malignant melanoma of the ascending colon received adjuvant therapy consisting of immunotherapy with PD-1 inhibitors.
Irgen Tafaj, PhD
Advertisement
Articles by Irgen Tafaj, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Purple Reign Vs Thriller: A Duel of The Top Frontline EGFR+ NSCLC Regimens
2
ASCO Breakthrough 2026 Wrap-Up: Precision Oncology, AI, and Biomarkers Define the Future of Cancer Care
3
MARIPOSA Trial: EGFR-Mutant Lung Cancer Frontline Strategies
4
Teclistamab Induction Shows Feasibility in Transplant-Eligible Myeloma
5